{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "07d08828-39be-453d-9c15-7d0737ceb72f",
   "metadata": {},
   "source": [
    "# Module_1: *Alzheimer's Research Project*\n",
    "\n",
    "## Team Members:\n",
    "*Gabby Holohan & Jack Hancock*\n",
    "\n",
    "## Project Title:\n",
    "*The Effect of the APOE genotype on the Age of Onset of Alzheimers*\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8372d796-186a-4ae2-9b4f-0065979e555a",
   "metadata": {},
   "source": [
    "## Project Goal:\n",
    "This project seeks to investigate the impact of the APOE genotype on the age of onset of Alzheimer's symptoms for patients treated in the US."
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "id": "91408b75-185a-4d66-9ce7-7c7aabbde5e1",
   "metadata": {},
   "source": [
    "## Disease Background: \n",
    "*Fill in information about 11 bullets:*\n",
    "\n",
    "* Prevalence & incidence\n",
    "\n",
    "    - Prevalence: In 2025, about 7.2 million Americans age 65 and older are living with Alzheimer’s dementia. That is about 1 in 9 people age 65+. Throughout the world, this number is 55 million (2024).\n",
    "    - Incidence: For ages 65-69: about 2.8 per 1,000 person-years\n",
    "    https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf \n",
    "* Economic burden\n",
    "    - estimated at over $360 billion annually in the U.S. alone (2024), including direct health care costs, long-term care, and unpaid caregiving. The out-of-pocket expenses for patients and caregivers is estimated at 91 billion\n",
    "    https://curealz.org/the-basics-of-alzheimers-disease/statistics-and-costs/?\n",
    "* Risk factors (genetic, lifestyle):\n",
    "\n",
    "    - Less than 1% purely genetic (disease almost guaranteed)-->develop middle age\n",
    "    - environmental risk factors: older age, increased chances if 1st degree relative had disease --> familial genetic factors not understood yet, apolipoprotein E (APOE) gene -- APOE e4 increases risk - 25-30% of population carries APOE e4 but not all develop disease - having two copies AOE e4 increases risk more than 1, some rare changes in genes that almost ensure Alzheimer's onset but very rare <1%, down syndrome more likely (3 copies chromosome 21 - gene involved in producing protein leading to creation of Beta-amyloid) --> symptoms occur 10-20yrs earlier w/ down syndrome, overall more women w/ Alz bc they tend to live longer, mild cognitive impairment (MCI) can be at higher risk for Alz, traumatic brain injurgy (TBI) for 50+ --> more risk w/ more severe or multiple, air pollution exposure, heavy alcohol use --> also early onset, poor sleep patterns, lifestyle risks:\n",
    "    - lack of exercise, \n",
    "    - obesity, \n",
    "    - smoking/secondhand exposure\n",
    "https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447\n",
    "* Societal determinants\n",
    "    - lower education level may coorelate to poorer brain health\n",
    "    - for 45+ reporting symptoms of decining memory and frequent confusion: 2x as many w/o hs degree & lowest for college grads\n",
    "    - potentially due to cognitive reserve\n",
    "    - access to health care: early dx for other health issues, prevent chronic disease\n",
    "    - built environment: unsafe or unhealthy environments can impact brain health, can influence behavior (ex: running, eating healthy, sidewalks, etc)\n",
    "    - loneliness increases risk of premature death (for everything) & people socially isolated or lonely at higher risk for dementia\n",
    "    - https://www.cdc.gov/alzheimers-dementia/php/sdoh/index.html\n",
    "\n",
    "* Symptoms \n",
    "    - repeating statements/questions, forgetting things, misplacing items, getting lost in familiar places, forgetting names of people/ objects, having trouble conversating\n",
    "trouble concentrating/thinking (math, multiple tasks, etc) --> eventually may not recognize numbers\n",
    "    - difficulty decision making\n",
    "    - trouble planning or doing simple tasks (getting dressed)\n",
    "    - changes in personality/behavior (depressed, withdrawn, distrusting, anger, sleeping habits changing, delusions, wandering, losing inhibitions)\n",
    "    - Some preserved skills --> things people can do even late-stage\n",
    "https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447\n",
    "\n",
    "* Diagnosis\n",
    "    - neurologist or doctor reviews symptoms, medical & medicine history\n",
    "    - physical exam (past strokes, prakinson's, depression, sleep apnea, etc)\n",
    "    - mental status testing --> tests cognitive ability\n",
    "    - lab tests: check for other conditions or cerebrospinal fluid test (measuring amyloid beta and tau in fluid)\n",
    "    - MRI, CT, PET (can recognize plaques or tau tangles, but mostly in research setting)\n",
    "    - new blood tests being developed measuring amyloid & tau content\n",
    "    - https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/alzheimers/art-20048075\n",
    "\n",
    "* Standard of care treatments (& reimbursement) \n",
    "* Disease progression & prognosis\n",
    "    - preclinical stage: mild memory loss, no significant impairment, pathological changes in entorhinal cortex 1st then hippocampus\n",
    "    - Mild Alzheimer's disease: forgetting new information and appointments, impaired problem solving and judgement, mood swings and personality changes, pathological changes reach cerebral cortex\n",
    "    - Moderate Alzheimer's disease: pathological changes further affect cerebral cortex (language, reasoning and sensory processing), more severe symptoms, behavioral issues and social isolation, language disorder\n",
    "    - Severe Alzheimer's disease: lose independence in simple tasks/daily activities, pathological damage covers all cortex areas, cognitive abilities reach lowest state, difficulty performing motor tasks, sleep disturbance, extrapyramidal motor signs\n",
    "    - No cure, continue to decline until death\n",
    "* Continuum of care providers\n",
    "* Biological mechanisms (anatomy, organ physiology, cell & molecular physiology)\n",
    "    - common features among subjects include synaptic loss, accumulation of plaques, and tau tangles\n",
    "    - neurotic plaques --> amyloid beta peptide comes from precursor protein APP, cleaved by alpha, beta, and gamma secretase\n",
    "    - people w/o AD: APP cleaved by alpha secretase --> cannot form amyloid beta peptide\n",
    "    - people w/ AD: APP cleaved by beta secretase then gamma secretase resulting in amyloid beta 40, 42, C99 amino acid peptides\n",
    "    - increased AB42 results in oligomers that cluster around meningeal and cerebral vessels and gray matter, forming plaques\n",
    "    - neurofibrillary tangles --> formed by tau\n",
    "    - tau normally binds to microtubules and has phosphates attached\n",
    "    - phosphorylation of tau is altered in AD, increasing phosphorylation (mechanics not yet understood)\n",
    "    - causes tau to detach from microtubules and be hyper-phosphorylated --> filamentous structures called paired helical filaments which are insoluble\n",
    "    - tangles start in transentorhinal cortex spread to hippocampus then cover cerebral cortex\n",
    "    - hippocampal pyramidal cells: granulo-vacuolar degeneration\n",
    "    - decrease in synaptic buttons associated with vascular degeneration\n",
    "    - increases the risk and degree/progression of dementia, but mechanisms not yet understood\n",
    "    https://pmc.ncbi.nlm.nih.gov/articles/PMC7815481/\n",
    "\n",
    "* Clinical Trials/next-gen therapies"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0a6c1ef0",
   "metadata": {
    "vscode": {
     "languageId": "plaintext"
    }
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "3b99aefb-cb03-4bd8-b972-437eb0e02dfe",
   "metadata": {},
   "source": [
    "## Data-Set: \n",
    "Data from the Allen Institute was used to determine the relationship between the APOE genotype and the age of onset of Alzheimer's. The Allen Institute's \"Integrated multimodal cell atlas of Alzheimer's disease\" used raw sequencing reads from ten unique public datasets, hosted on Synapse and the SRA, focused on the prefrontal cortex. Additionally, the Allen Institute's Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD) team applied snRNA-seq, snATAC-seq, snMultiome, and MERFISH methods to study cells and nuclei from post-mortem human brain tissue provided by the Adult Changes in Thought (ACT) study and the University of Washington's Alzheimer's Disease Research Center (ADRC). Data from SEA-AD and the public databases include demographic information, diagnoses, and genotypes. Molecular data were expressed as gene expression counts, chromatin peak accessibility, and spatial coordinates. All data are from US donors."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b994f1f0",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "attachments": {
    "Figure_1.png": {
     "image/png": "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"
    }
   },
   "cell_type": "markdown",
   "id": "f4cde622-5508-4a54-aba8-77b454138bff",
   "metadata": {},
   "source": [
    "## Data Analyis: \n",
    "Python was used to generate a bar graph comparing the age of symptomatic onset of subjects with a present APOE E4 allele and subjects without the APOE E4 allele. The bar graph shows that the average age of onset for subjects with the APOE E4 allele is lower than the subjects without the APOE E4 allele. A Students T-test was performed, producing a t-value of -3.6149 and a p-value of 0.002009. The p-value indicates a statistically significant difference between the groups is present on a 95% confidence interval.\n",
    "\n",
    "* ![APOE Genotype vs Age of Onset](attachment:Figure_1.png)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6aeea7f2",
   "metadata": {},
   "outputs": [],
   "source": [
    "import csv\n",
    "import re\n",
    "import matplotlib.pyplot as plt\n",
    "from scipy import stats\n",
    "\n",
    "# ---------- Data model ----------\n",
    "class Patient:\n",
    "    all_patients = []  # collect every created Patient\n",
    "\n",
    "    def __init__(self, donor_id, apoe, age_onset, age_diag, sex):\n",
    "        self.donor_id = donor_id\n",
    "        self.apoe = apoe\n",
    "        self.age_onset = age_onset\n",
    "        self.age_diag = age_diag\n",
    "        self.sex = sex\n",
    "        Patient.all_patients.append(self)\n",
    "\n",
    "    def __repr__(self):\n",
    "        return (f\"Patient(ID={self.donor_id}, APOE={self.apoe}, \"\n",
    "                f\"Onset={self.age_onset}, Diagnosis={self.age_diag}, Sex={self.sex})\")\n",
    "\n",
    "\n",
    "# ---------- Helpers ----------\n",
    "def _norm_header(s: str) -> str:\n",
    "    \"\"\"Normalize a header for resilient matching (lowercase, alnum only).\"\"\"\n",
    "    return re.sub(r'[^0-9a-z]+', '', (s or '').lower())\n",
    "\n",
    "def _resolve(headers, candidates_norm_keys):\n",
    "    \"\"\"\n",
    "    Resolve an actual header name from a list of candidate normalized keys.\n",
    "    Returns the matched real header or None.\n",
    "    \"\"\"\n",
    "    norm_map = {_norm_header(h): h for h in headers if h is not None}\n",
    "    for key in candidates_norm_keys:\n",
    "        if key in norm_map:\n",
    "            return norm_map[key]\n",
    "    return None\n",
    "\n",
    "def _clean_missing(val):\n",
    "    \"\"\"Map common missing markers to None; strip whitespace.\"\"\"\n",
    "    v = (val or \"\").strip()\n",
    "    return None if v.lower() in {\"\", \"na\", \"n/a\", \"nan\", \"none\", \"null\", \".\"} else v\n",
    "\n",
    "def _clean_number_like(val):\n",
    "    \"\"\"\n",
    "    Parse numbers: '81.0' -> '81' for display; but we return as float for analysis.\n",
    "    Returns float or None.\n",
    "    \"\"\"\n",
    "    v = _clean_missing(val)\n",
    "    if v is None:\n",
    "        return None\n",
    "    try:\n",
    "        return float(v)\n",
    "    except:\n",
    "        return None\n",
    "\n",
    "\n",
    "# ---------- Loader (skips rows with NO onset-of-symptoms value) ----------\n",
    "def load_patients_from_csv(filepath=\"NO DATE GENOTYPE Metadata (1).csv\"):\n",
    "    \"\"\"\n",
    "    Create Patient objects from the CSV, skipping rows with NO onset-of-symptoms value.\n",
    "    \"\"\"\n",
    "    # Clear any prior loaded patients if you re-run\n",
    "    Patient.all_patients.clear()\n",
    "\n",
    "    with open(filepath, newline='', encoding=\"utf-8\") as csvfile:\n",
    "        reader = csv.DictReader(csvfile)\n",
    "        headers = reader.fieldnames or []\n",
    "\n",
    "        # Resolve columns robustly (tolerate spacing/case variations)\n",
    "        donor_col = _resolve(headers, [\"donorid\", \"donor_id\", \"id\", \"donoridnumber\"])\n",
    "        apoe_col  = _resolve(headers, [\"apoegenotype\", \"apoe\", \"apoe_genotype\", \"apoegenotype\", \"apoe(genotype)\"])\n",
    "        onset_col = _resolve(headers, [\"ageofonsetcognitivesymptoms\", \"ageofonset\", \"onsetage\", \"ageatcognitivesymptomonset\"])\n",
    "        diag_col  = _resolve(headers, [\"ageofdementiadiagnosis\", \"ageatdiagnosis\", \"diagnosisage\"])\n",
    "        sex_col   = _resolve(headers, [\"sex\", \"gender\"])\n",
    "\n",
    "        for row in reader:\n",
    "            donor_id  = _clean_missing(row.get(donor_col, \"\") if donor_col else None)\n",
    "            apoe_raw  = _clean_missing(row.get(apoe_col,  \"\") if apoe_col  else None)\n",
    "            age_onset = _clean_number_like(row.get(onset_col, \"\") if onset_col else None)\n",
    "            age_diag  = _clean_number_like(row.get(diag_col,  \"\") if diag_col  else None)\n",
    "            sex       = _clean_missing(row.get(sex_col,   \"\") if sex_col   else None)\n",
    "\n",
    "            # Skip entries with NO onset-of-symptoms value\n",
    "            if age_onset is None:\n",
    "                continue\n",
    "\n",
    "            # Normalize APOE string formatting (e.g., strip spaces)\n",
    "            apoe = apoe_raw.replace(\" \", \"\") if apoe_raw else None\n",
    "\n",
    "            Patient(donor_id, apoe, age_onset, age_diag, sex)\n",
    "\n",
    "\n",
    "# ---------- Grouping, Printing, T-test, and Plot ----------\n",
    "def apoe_group_label(apoe: str) -> str:\n",
    "    \"\"\"\n",
    "    Per instructions:\n",
    "      - Group '3/4' and '4/4' as 'E4 Present'\n",
    "      - All other genotypes -> 'E4 Not Present'\n",
    "    \"\"\"\n",
    "    if not apoe:\n",
    "        return \"E4 Not Present\"\n",
    "    apoe_norm = apoe.strip()\n",
    "    return \"E4 Present\" if apoe_norm in {\"3/4\", \"4/4\"} else \"E4 Not Present\"\n",
    "\n",
    "def print_transformed_data():\n",
    "    \"\"\"\n",
    "    Print the transformed data: Donor ID, E4-group label, Age of Onset.\n",
    "    \"\"\"\n",
    "    print(\"DonorID\\tGroup\\t\\tAgeOnset\")\n",
    "    for p in Patient.all_patients:\n",
    "        group = apoe_group_label(p.apoe)\n",
    "        # Align group label for readability\n",
    "        pad = \"\\t\" if group == \"E4 Present\" else \"\\t\"\n",
    "        print(f\"{p.donor_id or ''}\\t{group}{pad}{int(p.age_onset) if p.age_onset.is_integer() else p.age_onset}\")\n",
    "\n",
    "def analyze_and_plot():\n",
    "    \"\"\"\n",
    "    Create two groups (E4 Present vs E4 Not Present), run Student's t-test,\n",
    "    and make a 2-bar plot of mean Age of Onset for each group.\n",
    "    \"\"\"\n",
    "    e4_present = []\n",
    "    e4_not_present = []\n",
    "\n",
    "    for p in Patient.all_patients:\n",
    "        group = apoe_group_label(p.apoe)\n",
    "        onset = p.age_onset\n",
    "        if onset is None:\n",
    "            continue\n",
    "        if group == \"E4 Present\":\n",
    "            e4_present.append(onset)\n",
    "        else:\n",
    "            e4_not_present.append(onset)\n",
    "\n",
    "    # Basic safety checks\n",
    "    if len(e4_present) == 0 or len(e4_not_present) == 0:\n",
    "        print(\"Not enough data to compare groups.\")\n",
    "        print(f\"E4 Present count: {len(e4_present)}, E4 Not Present count: {len(e4_not_present)}\")\n",
    "        return\n",
    "\n",
    "    # Means\n",
    "    mean_present = sum(e4_present) / len(e4_present)\n",
    "    mean_not = sum(e4_not_present) / len(e4_not_present)\n",
    "\n",
    "    # --- Bar plot with two bars (no specific colors per instruction constraints) ---\n",
    "    labels = [\"E4 Present\", \"E4 Not Present\"]\n",
    "    means = [mean_present, mean_not]\n",
    "\n",
    "    plt.figure()\n",
    "    plt.bar(labels, means)\n",
    "    plt.ylabel(\"Mean Age of Onset (years)\")\n",
    "    plt.title(\"APOE (Grouped) vs Age of Onset\")\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "\n",
    "    # --- Student's t-test (Welch's version: robust to unequal variances) ---\n",
    "    tval, pval = stats.ttest_ind(e4_present, e4_not_present, equal_var=False)\n",
    "\n",
    "    print(\"\\n--- Statistical Comparison (Student's t-test, Welch) ---\")\n",
    "    print(f\"Group sizes: E4 Present n={len(e4_present)}, E4 Not Present n={len(e4_not_present)}\")\n",
    "    print(f\"Means: E4 Present = {mean_present:.2f}, E4 Not Present = {mean_not:.2f}\")\n",
    "    print(f\"t-value = {tval:.4f}\")\n",
    "    print(f\"p-value = {pval:.6f}\")\n",
    "    if pval < 0.05:\n",
    "        print(\"Result: Statistically significant difference at α = 0.05\")\n",
    "    else:\n",
    "        print(\"Result: Not statistically significant at α = 0.05\")\n",
    "\n",
    "\n",
    "# ---------- Run everything ----------\n",
    "if __name__ == \"__main__\":\n",
    "    # 1) Load patients from the provided CSV, skipping rows with no onset age\n",
    "    load_patients_from_csv(\"NO DATE GENOTYPE Metadata (1).csv\")\n",
    "\n",
    "    # 2) Print transformed data (APOE collapsed into two groups; print age of onset)\n",
    "    print_transformed_data()\n",
    "\n",
    "    # 3) Make two-bar plot and run t-test\n",
    "    analyze_and_plot()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5c67b6a4-ec94-4d28-b2a7-f6b860495118",
   "metadata": {},
   "source": [
    "## Verify and validate your analysis: \n",
    "*(Describe how you checked to see that your analysis gave you an answer that you believe (verify). Describe how your determined if your analysis gave you an answer that is supported by other evidence (e.g., a published paper).*"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2736cf95-2b93-444f-90c8-d40a54fc1df1",
   "metadata": {},
   "source": [
    "## Conclusions and Ethical Implications: \n",
    "*(Think about the answer your analysis generated, draw conclusions related to your overarching question, and discuss the ethical implications of your conclusions.*"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f023b735-6efb-43ed-a03d-eb4a9cdb734e",
   "metadata": {},
   "source": [
    "## Limitations and Future Work: \n",
    "*(Think about the answer your analysis generated, draw conclusions related to your overarching question, and discuss the ethical implications of your conclusions.*"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ff46e22b",
   "metadata": {},
   "source": [
    "## Team Notes:\n",
    "* 9/09/25: Began research on Alzheimer's Disease\n",
    "* 9/11/25: Chose a research question (APOE genotype's effect on age of onset), continued research, discussed team communication\n",
    "* 9/16/25: Began developing code to separate E4 carriers and non-carriers\n",
    "* 9/17/25: Went to office hours to troubleshoot code, finished bar graph\n",
    "* 9/18/25: Presented current findings and performed Students T-test"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4b7195ff",
   "metadata": {},
   "source": [
    "## Questions for TAs:\n",
    "We have no questions at this point in time."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [conda env:base] *",
   "language": "python",
   "name": "conda-base-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
